KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nu Skin Enterprises (NUS) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Nu Skin Enterprises (NUS) over the last 17 years, with Q4 2025 value amounting to $238.7 million.

  • Nu Skin Enterprises' Operating Expenses fell 2814.06% to $238.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $965.6 million, marking a year-over-year decrease of 2758.3%. This contributed to the annual value of $965.6 million for FY2025, which is 2758.3% down from last year.
  • Latest data reveals that Nu Skin Enterprises reported Operating Expenses of $238.7 million as of Q4 2025, which was down 2814.06% from $235.1 million recorded in Q3 2025.
  • Nu Skin Enterprises' 5-year Operating Expenses high stood at $479.3 million for Q4 2021, and its period low was $235.0 million during Q2 2025.
  • Over the past 5 years, Nu Skin Enterprises' median Operating Expenses value was $334.3 million (recorded in 2023), while the average stood at $343.9 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first surged by 3430.23% in 2024, then plummeted by 4570.5% in 2025.
  • Nu Skin Enterprises' Operating Expenses (Quarter) stood at $479.3 million in 2021, then fell by 27.6% to $347.1 million in 2022, then fell by 3.08% to $336.4 million in 2023, then dropped by 1.23% to $332.2 million in 2024, then fell by 28.14% to $238.7 million in 2025.
  • Its Operating Expenses was $238.7 million in Q4 2025, compared to $235.1 million in Q3 2025 and $235.0 million in Q2 2025.